Considerations on Discontinuing Natalizumab for the Treatment of Multiple Sclerosis

被引：37

作者：

Berger, Joseph R. ^{[1
]}

Centonze, Diego ^{[2
,3
]}

Comi, Giancarlo ^{[4
]}

Confavreux, Christian ^{[5
]}

Cutter, Gary ^{[6
]}

Giovannoni, Gavin ^{[7
]}

Gold, Ralf ^{[8
]}

Hartung, Hans-Peter ^{[9
]}

Lublin, Fred ^{[10
]}

Miravalle, Augusto ^{[11
]}

Montalban, Xavier ^{[12
]}

O'Connor, Paul ^{[13
]}

Olsson, Tomas ^{[14
]}

Polman, Chris H. ^{[15
]}

Stuve, Olaf ^{[16
]}

Wolinsky, Jerry S. ^{[17
]}

Ziemssen, Tjalf ^{[18
]}

机构：

[1] Univ Kentucky, Coll Med, Dept Neurol, Lexington, KY 40506 USA

[2] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy

[3] Santa Lucia Fdn, Rome, Italy

[4] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy

[5] Pierre Wertheimer Neurol Hosp, Lyon, France

[6] Univ Alabama, Dept Biostat, Birmingham, AL 35294 USA

[7] Dept Neurol, London, England

[8] Ruhr Univ Bochum, Dept Neurol, Bochum, Germany

[9] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany

[10] Mt Sinai Sch Med, Dept Neurol, New York, NY USA

[11] Univ Colorado, Dept Neurol, Denver, CO 80202 USA

[12] Univ Hosp Vall dHebron, Dept Neurol, Barcelona, Spain

[13] St Michaels Hosp, Dept Neurol, Toronto, ON M5B 1W8, Canada

[14] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden

[15] Free Univ Amsterdam, Dept Neurol, Amsterdam, Netherlands

[16] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA

[17] Univ Texas Hlth Sci Ctr, Dept Neurol, Houston, TX USA

[18] Tech Univ Dresden, Dept Neurol, Med Clin, Dresden, Germany

来源：

ANNALS OF NEUROLOGY | 2010年 / 68卷 / 03期

关键词：

IMMUNE RECONSTITUTION SYNDROME; THERAPY; CESSATION; RELAPSES;

D O I：

10.1002/ana.22083

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：409 / 411

页数：3

共 8 条

[1]

Haartsen J, 2009, MULT SCLER, V15, pS245

[2] A controlled trial of natalizumab for relapsing multiple sclerosis. [J].

Miller, DH ;

Khan, OA ;

Sheremata, WA ;

Blumhardt, LD ;

Rice, GPA ;

Libonati, MA ;

Willmer-Hulme, AJ ;

Dalton, CM ;

Miszkiel, KA ;

O'Connor, PW .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) :15-23

[3]

Miravalle A, 2009, MULT SCLER J, V15, P1398

[4]

O'Connor PW, 2009, MULT SCLER, V15, pS240

[5]

Perini P, 2009, MULT SCLER, V15, pS234

[6]

Perumal J, 2009, MULT SCLER, V15, pS119

[7]

Pesci I, 2009, MULT SCLER, V15, pS121

[8] Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients [J].

Vellinga, M. M. ;

Castelijns, J. A. ;

Barkhof, F. ;

Uitdehaag, B. M. J. ;

Polman, C. H. .

NEUROLOGY, 2008, 70 (13) :1150-1151

← 1 →